Chemotherapy-induced peripheral neuropathy Four randomized controlled trials (RCTs) have evaluated the use of acetyl-L-carnitine (LC) for the prevention of chemotherapy-induced peripheral neuropathy (CIPN)
While a single study might show that GHK-Cu stimulates collagen, a comprehensive review reveals that it simultaneously activates tissue repair genes, suppresses inflammatory genes, promotes blood vessel growth genes, and resets age-related gene changes painting a far more complete picture than any single experiment could
Body composition studies in animal models have shown that sustained elevation of GH through this dual-pathway approach is associated with measurable changes in lean mass accretion and adipose tissue metabolism
However, the global supply of these medications remains limited, often resulting in a first-come, first-served distribution
It is essential to work with a qualified provider for proper dosing, timing, and follow-up